On-Demand Webinars

Unlocking Fast & Easy Molecular Classification of Endometrial Cancer Samples with the Idylla^TM POLE-POLD1 Mutation Assay

Biocartis Webinar 2025

Prof. Dr. Sigurd F. Lax, Christine Weyn, PhD. & Ludovic Barault, PhD.

Same-day Molecular Testing Results From Cytology Specimens: The Next Frontier Of Rapid On-site Evaluation? Optimizing Small Biopsy Workflows With Idylla^TM

AMP Workshop 2024

Dr. Gloria Sura

The Importance of Fast Biomarker Testing in Breast Cancer

Biocartis Webinar 2024

Dr. Claus Hann von Weyhern, Prof. Daniele Generali, MD DPhil & Prof. Dr. Sigurd F. Lax

Rapid qPCR based IDH1/IDH2 mutation screening in solid tumors and hematologic malignancies without extraction

AMP Workshop 2023

Dr. Tejus A. Bale, MD-PhD.

Q&A Biocartis Symposium ECP 2022 Basel

ECP Congress 2022

Prof. Dr. Jesus Garcia-Foncillas MD PhD, Dr. Alison Finall, Prof. Dr. Arndt Hartmann med

Multicenter NSCLC comparison study using Idylla^TM GeneFusion

ECP Congress 2022

Prof. Dr. Arndt Hartmann med.

Idylla^TM MSI Assay as a new tool for the detection of microsatellite instability

ECP Congress 2021

Dr. Anaïs Pujals

Feasibility of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy NSCLC samples

ECP Congress 2021

Dr. Umberto Malapelle

Multicenter study using the Idylla^TM GeneFusion prototype cartridge

ECP Congress 2021

Dr. Audrey Lupo

The Value of Idylla^TM in Times of COVID-19 Pandemic

Biocartis Webinar 2021

Dr. Umberto Malapelle

Idylla^TM MSI Testing in Colorectal and Endometrial Cancer

ECP Congress 2019

Xavier Matias-Guiu Guia, M.D.

Idylla^TM GeneFusion: Revolutionary Precision Testing for Gene Rearrangements

ECP Congress 2022

Bieke Van Dorst, PhD, Senior Scientist

Unlocking Fast & Easy Molecular Classification of Endometrial Cancer Samples with the IdyllaTM POLE-POLD1 Mutation Assay

Same-day Molecular Testing Results From Cytology Specimens: The Next Frontier Of Rapid On-site Evaluation? Optimizing Small Biopsy Workflows With IdyllaTM

The Importance of Fast Biomarker Testing in Breast Cancer

Rapid qPCR based IDH1/IDH2 mutation screening in solid tumors and hematologic malignancies without extraction

Q&A Biocartis Symposium ECP 2022 Basel

Multicenter NSCLC comparison study using IdyllaTM GeneFusion

IdyllaTM MSI Assay as a new tool for the detection of microsatellite instability

Feasibility of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy NSCLC samples

Multicenter study using the IdyllaTM GeneFusion prototype cartridge

The Value of IdyllaTM in Times of COVID-19 Pandemic

IdyllaTM MSI Testing in Colorectal and Endometrial Cancer

IdyllaTM GeneFusion: Revolutionary Precision Testing for Gene Rearrangements

Unlocking Fast & Easy Molecular Classification of Endometrial Cancer Samples with the Idylla^TM POLE-POLD1 Mutation Assay

Same-day Molecular Testing Results From Cytology Specimens: The Next Frontier Of Rapid On-site Evaluation? Optimizing Small Biopsy Workflows With Idylla^TM

Multicenter NSCLC comparison study using Idylla^TM GeneFusion

Idylla^TM MSI Assay as a new tool for the detection of microsatellite instability

Multicenter study using the Idylla^TM GeneFusion prototype cartridge

The Value of Idylla^TM in Times of COVID-19 Pandemic

Idylla^TM MSI Testing in Colorectal and Endometrial Cancer

Idylla^TM GeneFusion: Revolutionary Precision Testing for Gene Rearrangements